A detailed history of Gts Securities LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 39,600 shares of PACB stock, worth $64,547. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,600
Previous 61,100 35.19%
Holding current value
$64,547
Previous $229,000 76.42%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $4,700 - $12,614
-3,456 Reduced 9.23%
33,989 $46,000
Q1 2024

May 15, 2024

SELL
$3.52 - $9.59 $982,396 - $2.68 Million
-279,090 Reduced 88.17%
37,445 $140,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $572,779 - $993,969
95,943 Added 43.49%
316,535 $3.11 Million
Q3 2023

Nov 15, 2023

BUY
$8.23 - $13.93 $105,286 - $178,206
12,793 Added 6.16%
220,592 $1.84 Million
Q2 2023

Aug 15, 2023

BUY
$9.97 - $14.05 $2.07 Million - $2.92 Million
207,799 New
207,799 $2.76 Billion

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $366M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.